BioNTech SE (ETR:22UA)
95.30
-2.20 (-2.26%)
Last updated: Jul 14, 2025
BioNTech SE Employees
BioNTech SE had 6,772 employees as of December 31, 2024. The number of employees increased by 639 or 10.42% compared to the previous year.
Employees
6,772
Change (1Y)
639
Growth (1Y)
10.42%
Revenue / Employee
€405,538
Profits / Employee
€113,113
Market Cap
23.77B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Sartorius Aktiengesellschaft | 13,528 |
Fresenius Medical Care AG | 111,513 |
Fielmann Group AG | 24,363 |
Carl Zeiss Meditec AG | 5,730 |
BioNTech SE News
- 4 days ago - Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win - Reuters
- 7 days ago - Family offices ramp up deal-making in June with bets on biotech - CNBC
- 13 days ago - Instil Bio: Chasing After Summit And BioNTech, Albeit With Some Hiccups - Seeking Alpha
- 19 days ago - Amarin Lands Massive European Commercialization Deal For Heart Drug Vazkepa, Stock Surges - Benzinga
- 27 days ago - 5 Stocks To Ride The German Market Rally - Benzinga
- 4 weeks ago - Key deals this week: BioNTech, UnitedHealth, Qualcomm, Papa John's and more - Seeking Alpha
- 4 weeks ago - BioNTech's Acquisition Of CureVac Brings Complementary Method To Target Cancer - Seeking Alpha
- 4 weeks ago - BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal - Benzinga